|
[1]BALE SS, VERNETTI L, SENUTOVITCH N, et al.In vitro platforms for evaluating liver toxicity[J].Exp Biol Med (Maywood) , 2014, 239 (9) :1180-1191.
|
|
[2]REN ZQ, WANG JH, LI H, et al.Multidisciplinary expert consensus on clinical features and prognosis of drug-induced liver injury[J].World Chin J Dig, 2016, 24 (8) :1257-1263. (in Chinese) 任张青, 王进海, 李浩, 等.药物性肝损伤临床特征及预后多学科专家共识[J].世界华人消化杂志, 2016, 24 (8) :1257-1263.
|
|
[3]LIU FF, DUAN XZ, ZANG H, et al.Analysis of the clinical characteristics of different types of drug-induced acute liver injury[J].Prog Mod Biomed, 2013, 13 (10) :1918-1921. (in Chinese) 柳芳芳, 段学章, 臧红, 等.不同类型急性药物性肝损伤的临床特点分析[J].现代生物医学进展, 2013, 13 (10) :1918-1921.
|
|
[4]YAO F, WANG YY.Statistic analysis of the 9355 patients with drug induced liver injury[J].Anhui Med Pharm J, 2011, 15 (10) :1312-1314. (in Chinese) 姚飞, 汪燕燕.综合分析药物性肝损伤9355例[J].安徽医药, 2011, 15 (10) :1312-1314.
|
|
[5]HU Q, LIU W, SHAO H.Research progress of pharmacotherapy drug-induced liver injury[J].Chin J Clin Pharmacol Ther, 2016, 21 (2) :231-236. (in Chinese) 胡琴, 刘维, 邵宏.药物性肝损伤的药物治疗研究进展[J].中国临床药理学与治疗学, 2016, 21 (2) :231-236.
|
|
[6]SEBODE M, SCHULZ L, LOHSE AW."Autoimmune (-Like) "drug and herb induced liver injury:new insights into molecular pathogenesis[J].Int J Mol Sci, 2017, 18 (9) :1-22.
|
|
[7]HUANG CY, LIU YM, HUANG YL, et al.Drug-induced liver injury accompanied by autoimmune phenomena:an analysis of clinical characteristics[J].J Clin Hepatol, 2015, 31 (8) :1303-1306. (in Chinese) 黄春洋, 刘燕敏, 黄云丽, 等.药物性肝损伤患者伴自身免疫现象的临床特点分析[J].临床肝胆病杂志, 2015, 31 (8) :1303-1306.
|
|
[8]OSTAPOWICZ G, FONTANA RJ, SCHIODT FV, et al.Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States[J].Ann Intern Med, 2002, 137 (12) :947-954.
|
|
[9]KAPLOWITZ N.Case definition and phenotype standardization in drug-induced liver injury[J].Clin Pharmacol Ther, 2011, 89 (6) :806-815.
|
|
[10]KHOURY T, RMEILEH AA, YOSHA L, et al.Drug induced liver injury:review with a focus on genetic factors, tissue diagnosis, and treat-ment options[J].Clin Transl Hepatol, 2015, 3 (2) :99-108.
|
|
[11]LEE WM.Drug-induced acute liver failure[J].Clin Liver Dis, 2013, 17:575-586, viii.
|
|
[12]ANDRADE RJ, LUCENA MI, FERNANDEZ MC, et al.Drug-induced liver injury:an analysis of 461 incidences submitted to the Spanish registry over a 10-year period[J].Gastroenterology, 2005, 129 (2) :512-521.
|
|
[13]LEWIS JH.Drug-induced liver disease[J].Med Clin North Am, 2000, 84 (5) :1275-1311.
|
|
[14]TENG GJ, SUN Y, CHANG BX, et al.The clinical features and prognosis analysis of 418 patients with drug-induced liver injury[J].Chin Hepatol, 2013, 18 (1) :11-14. (in Chinese) 滕光菊, 孙颖, 常彬霞, 等.418例药物性肝损害临床特征及预后分析[J].肝脏, 2013, 18 (1) :11-14.
|
|
[15]YAO YJ, LIU HL, ZHU B, et al.Analysis of clinical features and pathological change in 441 patients with drug-induced liver injuries[J].J Pract Hepatol, 2015, 18 (3) :286-289. (in Chinese) 姚云洁, 刘鸿凌, 朱冰, 等.441例药物性肝损伤患者临床和肝组织病理学特征分析[J].实用肝脏病杂志, 2015, 18 (3) :286-289.
|
|
[16]CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966.
|
|
[17]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1768. (in Chinese) 中华医学会肝病学分会.药物性肝病学组药物性肝损伤诊治指南 (2015年版) [J].临床肝胆病杂志, 2015, 31 (11) :1752-1768.
|
|
[18]LUEDDE T, KAPLOWITZ N, SCHWABE RF.Cell death and cell death responses in liver disease:mechanisms and clinical relevance[J].Gastroenterology, 2014, 147 (4) :765-783.
|
|
[19]STEPHENS C, ANDRADE RJ, LUCENA MI.Mechanisms of drug-induced liver injury[J].Curr Opin Allergy Clin Immunol, 2014, 14:286-292.
|
|
[20]KAPLOWITZ N.Idiosyncratic drug hepatotoxicity[J].Nat Rev Drug Discov, 2005, 4 (6) :489-499.
|
|
[21]RUSSMANN S, JETTER A, KULLAK-UBLICK GA.Pharmacogenetics of drug-induced liver injury[J].Hepatology, 2010, 52 (2) :748-761.
|
|
[22]BROWNING BL, BROWNING SR.Haplotypic analysis of wellcome trust case control consortium data[J].Hum Genet, 2008, 123 (3) :273-280.
|
|
[23]GABRIEL SB, SCHAFFNER SF, NGUYEN H, et al.The structure of haplotype blocks in the human genome[J].Science, 2002, 296 (5576) :2225-2229.
|
|
[24]TANG NP, WANG Y, LI H, et al.Study on candidate biomarkers of drug liver toxicity based on genomics[C]//A collection of papers on science and technology of the fourth Chinese Youth Academy of Toxicology.2014:43. (in Chinese) 汤纳平, 王雁, 李华, 等.基于基因组学的药物肝毒性候选生物标志物的研究[C]//中国毒理学会第四届中青年学者科技论坛论文集.2014:43.
|
|
[25]KUBES P, MEHAL WZ.Sterile inflammation in the liver[J].Gastroenterology, 2012, 143 (5) :1158-1172.
|
|
[26]XU X, JI LS, LU LL, et al.Research advances in the pathogenesis of drug-induced liver injury[J].J Clin Hepatol, 2016, 32 (2) :382-385. (in Chinese) 许新, 纪莉莎, 芦琳琳, 等.药物性肝损伤发病机制的研究进展[J].临床肝胆病杂志, 2016, 32 (2) :382-385.
|
|
[27]FISHER K, VUPPALANCHI R, SAXENA R.Drug-induced liver injury[J].Arch Pathol Lab Med, 2015, 139:876-887.
|
|
[28]TAN XQ, YANG GQ, ZHANG L, et al.Research progress on CYP2E1 mediating toxicity by exogenous chemicals[J].China Occup Med, 2016, 43 (2) :234-236. (in Chinese) 谭孝琼, 杨光谦, 张林, 等.细胞色素P4502 E1介导外源性化合物毒性损伤研究进展[J].中国职业医学, 2016, 43 (2) :234-236.
|
|
[29]SHENG YJ, HE HY.Association between CYP2E1 and NAT2 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs:a meta-analysis[J].Infect Dis Info, 2017, 30 (4) :212-215. (in Chinese) 盛云建, 何鸿雁.CYP2E1和NAT2基因多态性与抗结核药物诱导的药物性肝损伤关系的荟萃分析[J].传染病信息, 2017, 30 (4) :212-215.
|
|
[30]WU X, LIU CL, XUE G, et al.Association between Chinese CYP2E1 polymorphisms and anti-tuberculosis drug-induced liver injury:a Meta analysis[J/CD].Chin J Clinicians:Electronic Edition, 2017, 11 (7) :1147-1152. (in Chinese) 武鑫, 刘春亮, 薛刚, 等.中国人细胞色素P450 2E1基因多态性与抗结核药物性肝损害关系的Meta分析[J/CD].中华临床医师杂志:电子版, 2017, 11 (7) :1147-1152.
|
|
[31]MARTINEZ-GIL N, FLORES-BELLVER W, AHENZAR-AROCA S, et al.CYP2E 1 in the human retinal pigmenl epithelium:expresion, activity and induction by ethanol[J].Invest Ophthalmol Vis Sci, 2015, 56 (11) :6855-6863.
|
|
[32]ROTH RA, GANEY PE.Intrinsic versus idiosyncratic drug-induced hepatotoxicity——two villains or one?[J].J Pharmacol Exp Ther, 2010, 332 (3) :692-697.
|
|
[33]ZHANG J, JIN Z, HU XX, et al.Efficient two-photon fluorescent probe for glutathione S-transferase detection and imaging in druginduced liver injury sample[J].Anal Chem, 2017, 89 (15) :8097-8103.
|
|
[34]JIANG J, ZHANG X, HUO R, et al.Association study of UGT1A9promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population[J].Pharmacogenomics J, 2015, 15 (4) :326-331.
|
|
[35]YLVA T, FIGLER RA, SVETLANA M, et al.Transcriptional profiling suggests that nevirapine and ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes[J].Chem Biol Interact, 2016, 255:31-44.
|
|
[36]STICKEL F.Letter to the editor“Genetic polymorphisms in the UDP-glucuronosyltransferase UGT1A7 gene in patients with acute liver failure after kava-kava consumption”[J].Arch Toxicol, 2015, 89 (11) :2175-2176.
|
|
[37]ZOLNER G, TRAUNER M.Molecular mechanism of cholestasis[J].Wien Med Wochenschr, 2006, 156 (13-14) :380-385.
|
|
[38]FONTANA RJ.Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives[J].Gastroenterology, 2014, 146 (4) :914-928.
|
|
[39]KARCZMAREK-BOROWSKA B, SANEK-ZA N'A.Hepatotoxicity of molecular targeted therapy[J].Contemp Oncol (Pozn) , 2015, 19:87-92.
|
|
[40]KLEINER DE, CHALASANI NP, LEE WM, et al.Hepatic histological findings in suspected drug-induced liver injury:systematic evaluation and clinical associations[J].Hepatology, 2014, 59 (2) :661-670.
|
|
[41]PETROS Z, KISHIKAWA J, MAKONNEN E, et al.HLA-B*57Allele is associated with concomitant anti-tuberculosis and antiretroviral drugs induced liver toxicity in ethiopians[J].Front Pharmacol, 2017, 8:90.
|
|
[42]ZHANG ST, WAN GJ, LI L.Research advances in the mechanism of drug-induced liver injury[J].Pharm Care Res, 2017, 17 (1) :39-42. (in Chinese) 张守堂, 万国靖, 李璐.药物性肝损伤机制的研究进展[J].药学服务与研究, 2017, 17 (1) :39-42.
|
|
[43]BOELSTERLI UA, LEE KK.Mechanisms of isoniazid-induced idiosyncratic liver injury:emerging role of mitochondrial stress[J].J Gastroenterol Hepatol, 2014, 29 (4) :678-687.
|
|
[44]BHADAURIA S, MISHRA R, KANCHAN R, et al.Isoniazid-induced apopto-sis in Hep G2 cells:generation of oxidative stress and Bcl-2 down-regulation[J].Toxicol Mech Methods, 2010, 20:242-251.
|
|
[45]RAMACHANDRAN A, LEBOFSKY M, WEINMAN SA, et al.The impact of partial manganese superoxide dismutase (SOD2) -deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity[J].Toxicol Appl Pharmacol, 2011, 251 (3) :226-233.
|
|
[46]LEE SJ, LEE YJ, PARK KK.The pathogenesis of drug-induced liver injury[J].Expert Rev Gastroenterol Hepatol, 2016, 10 (10) :1-11.
|
|
[47]LUCENA MI, GARCIA-MARIFN E, ANDRADE RJ, et al.Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induce liver injury[J].Hepatology, 2010, 52 (1) :303-312.
|
|
[48]ANTONIADES CG, KHAMRI W, ABELES RD, et al.Secretory leukocyte protease inhibitor:a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure[J].Hepatology, 2014, 59 (4) :1564-1576.
|
|
[49]TAO MB, ZHANG L, LIU F, et al.Contains anthraquinones constituents of traditional Chinese medicine security research progress[C].Chinese Medicine and Natural Drug Toxicology Specialized Committee of Chinese Society of Toxicology First (2016) Academic Conference, 2016:108-115. (in Chinese) 陶明宝, 张乐, 刘飞, 等.含蒽醌类成分中药的安全性研究进展[C].中国毒理学会中药与天然药物毒理专业委员会第一次 (2016年) 学术交流大会, 2016:108-115.
|
|
[50]MA K, LIU YL.Research Progress on drug induced liver injury caused by traditional Chinese medicine[J].Guangming J Chin Med, 2015, 30 (4) :907-911. (in Chinese) 马昆, 刘燕玲.中药引起的药物性肝损伤研究进展[J].光明中医, 2015, 30 (4) :907-911.
|
|
[51]Branch of Hepatobiliary Diseases, China Association of Chinese Medicine, Branch of Chinese Patent Medicine, China Association of Chinese Medicine.Guidelines for the clinical management of herb-induced liver injury[J].J Clin Hepatol, 2016, 32 (5) :835-843. (in Chinese) 中华中医药学会肝胆病分会, 中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].临床肝胆病杂志, 2016, 32 (5) :835-843.
|
|
[52]PARK EJ, ZHAO YZ, KIM YC, et al.Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts[J].Eur J Pharmacol, 2007, 559 (2-3) :115-123.
|
|
[53]LI B, LI L, ZHAO JN, et al.Effect of Wu Zhuyu ethanol extract on acute toxicity and hepatotoxicity in rats[J].Pharmocol Clin Chin Mater Med, 2013, 29 (2) :120-124. (in Chinese) 李波, 李莉, 赵军宁, 等.吴茱萸乙醇提取物对大鼠急性毒性及肝毒性的影响[J].中药药理与临床, 2013, 29 (2) :120-124.
|
|
[54]MEI X, YU LQ, CHEN XY, et al.Advances in studies on the chemical components and pharmacological activities of Radix Polygoni multiflori[J].Drug Eval Res, 2016, 39 (1) :122-131. (in Chinese) 梅雪, 余刘勤, 陈小云, 等.何首乌化学成分和药理作用的研究进展[J].药物评价研究, 2016, 39 (1) :122-131.
|
|
[55]WANG Y, LI J, WU Z, et al.Insights into the molecular mechanisms of Polygonum multiflorum Thunb-induced liver injury:a computational systems toxicology approach[J].Acta Pharmacol Sin, 2017, 38 (5) :719-732.
|
|
[56]SU YW, CHEN X, JIANG ZZ, et al.A panel of serum microRNAs as specific biomarkers for diagnosis of compound-and herb-induced liver injury in rats[J].PLo S One, 2012, 7 (5) :e37395.
|
DownLoad: